NEW YORK (TheStreet) -- On CNBC's "Cramer's Stop Trading" segment, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, took a look at Rite Aid
The stock is down 17% from its 52-week highs due to "shortfalls" in the previous quarter, he said.
However, the company reported same-store sales growth of 3.9%, better than the 2.6% growth Cramer was looking for.
5 Retail Companies That Outperformed in 2014
Why IBM Is Worth $220 a Share
There's No Guarantee Apple and Google Will Crush Pandora
Exxon Mobil Goes Where Few Oil Giants Tread
He also likes Walgreen
, except the stock has been "pushed to extremes" by hedge funds.
Given Rite Aid's 17% decline, followed by its better-than-expected same-store sales results, it's time to "buy Rite Aid," he concluded.
-- Written by Bret Kenwell in Petoskey, Mich.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts